A systems biology analysis of lipolysis and fatty acid release from adipocytes in vitro and from adipose tissue in vivo.
Level 5 - mechanism / opinion, no new human data
Computational systems biology and mathematical modeling study (mechanism-based reasoning)
PubMed 34972146 · doi:10.1371/journal.pone.0261681
What was done
Authors developed an integrated mathematical systems biology model linking intracellular adipocyte lipolysis mechanisms (stimulated by catecholamines and inhibited by insulin) to systemic in vivo fatty acid release. The model was constructed by combining in vitro and in vivo data, tested against independent validation data not used during training, and applied to simulate fatty acid dynamics during an insulin clamp in individuals with and without type 2 diabetes.
What was found
The abstract reports no numerical values, effect sizes, or statistical metrics. It states qualitatively that the integrated model successfully explained the training datasets, described independent validation data, and simulated differences in extracellular fatty acid concentrations during an insulin clamp between non-diabetic and type 2 diabetic states.
Why it matters
This framework bridges cellular signaling pathways with whole-body metabolic kinetics, providing an in silico tool to explore mechanisms of dysregulated fatty acid release in type 2 diabetes.
Limits
The abstract provides no sample sizes, demographic characteristics, or quantitative parameters for the underlying datasets. Findings reflect computational simulations rather than new experimental or clinical measurements.
Cited by
- supports Norepinephrine signals adipose tissue to break down triglycerides and release fatty acids into the bloodstream.